Startup - Niramai Health Analytix

Key Management: Geetha Manjunath and Nidhi Mathur, Co-Founders

Nowadays, Breast cancer is the foremost reason of the cancer deaths of women, Niramai Health Analytix pioneers in the landscape of breast health by providing novel breast health screening solutions.

In order to eliminate the traditional methods and self-examination methods to cause suspected failures, the startup has developed AI-based medical technique called Thermalytix to detect breast cancer in a very early stage which is automated, portable, and accurate and designed to get the screening done at low costs.

It is available in across 300+ hospitals and screening centers of India, to name a few -Rainbow hospitals, Apollo clinics, Narayana Health, and many more, Niramai is available in almost 30 cities. Especially, the imaging solutions for breast cancer screening is completely free from harmful radiation, pain, human touch, deployed by only women for all the operations and procedures.

Funding Deal: Over 8 funding rounds, Niramai Health Analytix rose total funding of $14 million. In June 2021, the startup closed an undisclosed amount from British International Investment.

Competitors: Vayyar, Olive Healthcare, QT Imaging, and CairnSurgical

Summing up this, the robust surge of the inventive HeathTech startup is a significant leap towards building even-handed & more effective healthcare system in India. These healthTech innovators are breaking the conventional barriers in the system and articulating most advanced solutions that align with the unique requirements of the Indian people.

By leveraging cutting-edge technologies and fostering ultimate values of innovation, India is undergoing a huge transformation that drives better health outcome and setting global level standards for healthcare excellence.